# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 3

Extent: E+W+S+N.I.

For regulation 17 (amendment of regulation 36 (requirement for authorisation to manufacture or import investigational medicinal products)) substitute—
“17 In regulation 36(2), after “marketing authorization” insert “ or marketing authorisation issued by the competent authority of an EEA State in accordance with Directive 2001/83/EC ”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/1/paragraph/3 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-1/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.